$356.34+16.98% · 3M
Moving avg
1W+2.32%
1M+14.48%
3M+21.51%
6M+2.97%
YTD+14.57%
1Y+15.06%
3Y+74.56%
5Y+27.01%
52-week range
$253.9578% of range$385.22
Company health
Value2/6
Growth3/6
Profitability4/6
Health6/6
Dividend0/6
Bull vs bear
Strengths
- Reasonably valued at 5.0x earnings
- Analyst consensus is "Buy"
- High return on equity (1210%)
- Revenue compounding 73% a year
- Net cash on the balance sheet
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$38.08B
Enterprise value
$39.65B
P/E ratio (TTM)
5.05x
P/S ratio (TTM)
7.36x
EV/EBITDA
47.08x
Per share & returns
EPS (TTM)
$4.64
Dividend yield
0.00%
Beta (1Y)
0.49
30-day change
+14.48%
Trading
Volume (24h)
140.18K
Previous close
$359.05
Shares outstanding
106.86M
About BeOne Medicines AG
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
ONC
BeOne Medicines AG is a large-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ (Switzerland) and trade under the ticker ONC.
Frequently asked questions
What is BeOne Medicines AG's market cap?
BeOne Medicines AG (ONC) has a market capitalization of $38.08B.
What is BeOne Medicines AG's P/E ratio?
BeOne Medicines AG trades at a price-to-earnings (P/E) ratio of 5.05.
What exchange does ONC trade on?
ONC trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,217.09-0.26%
$1.15T cap
Johnson & JohnsonJNJ
$261.54+0.26%
$630.28B cap
AbbVie Inc.ABBV
$250.93+0.87%
$443.34B cap
UnitedHealth Group IncorporatedUNH
$402.43-0.78%
$365.46B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.59+1.26%
$332.41B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap